ID: ALA514166

Max Phase: Preclinical

Molecular Formula: C9H11FN5O9P

Molecular Weight: 383.19

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  [N-]=[N+]=Nc1c(F)c(=O)[nH]c(=O)n1[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C9H11FN5O9P/c10-3-6(13-14-11)15(9(19)12-7(3)18)8-5(17)4(16)2(24-8)1-23-25(20,21)22/h2,4-5,8,16-17H,1H2,(H,12,18,19)(H2,20,21,22)/t2-,4-,5-,8-/m1/s1

Standard InChI Key:  ARRBQQMKVQEOHQ-UMMCILCDSA-N

Associated Targets(Human)

Uridine 5'-monophosphate synthase 20 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Orotidine 5'-phosphate decarboxylase 39 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 383.19Molecular Weight (Monoisotopic): 383.0278AlogP: -1.65#Rotatable Bonds: 5
Polar Surface Area: 220.07Molecular Species: ACIDHBA: 9HBD: 5
#RO5 Violations: 0HBA (Lipinski): 14HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 1.23CX Basic pKa: CX LogP: -1.91CX LogD: -5.66
Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.17Np Likeness Score: 0.67

References

1. Bello AM, Konforte D, Poduch E, Furlonger C, Wei L, Liu Y, Lewis M, Pai EF, Paige CJ, Kotra LP..  (2009)  Structure-activity relationships of orotidine-5'-monophosphate decarboxylase inhibitors as anticancer agents.,  52  (6): [PMID:19260677] [10.1021/jm801224t]

Source